Brief: Nabriva Therapeutics Says Elected Lisa Dalton And Mark Corrigan As Members Of Board
03/06/2021 14:41
June 3 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS PLC - ELECTED LISA DALTON AND MARK
CORRIGAN
AS MEMBERS OF BOARD, EFFECTIVE IMMEDIATELY
* NABRIVA THERAPEUTICS PLC - BOARD INCREASED NUMBER OF
DIRECTORS
COMPRISING BOARD FROM EIGHT TO TEN
Source: (https://bit.ly/3yXbIRN)
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update